EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting

Tomislav Pejčić, Zoran Todorović iD, Siniša Đurašević iD, Lazar Popović iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032939 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Tomislav Pejčić und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 263 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, science and Technological Development of Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) is today the second most common cancer in the world, with almost 400,000 deaths annually. Multiple factors are involved in the etiology of PCa, such as older age, genetic mutations, ethnicity, diet, or inflammation. Modern treatment of PCa involves radical surgical treatment or radiation therapy in the stages when the tumor is limited to the prostate. When metastases develop, the standard procedure is androgen deprivation therapy, which aims to reduce the level of circulating testosterone, which is achieved by surgical or medical castration. However, when the level of testosterone decreases to the castration level, the tumor cells adapt to the new conditions through different mechanisms, which enable their unhindered growth and survival, despite the therapy. New knowledge about the biology of the so-called of castration-resistant PCa and the way it adapts to therapy will enable the development of new drugs, whose goal is to prolong the survival of patients with this stage of the disease, which will be discussed in this review.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstatic Neoplasms, Castration-ResistantMaleHumansAndrogen AntagonistsTestosteroneProstateOrchiectomyReceptors, Androgen

Stichwörter der Autor:innen

antiandrogen resistancecancernew drugsprostatetherapy

Substanzen

Androgen AntagonistsTestosteroneReceptors, Androgen

Autor:innen und Institutionen

  • Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
  • Clinic of Urology, University Clinical Centre of Serbia, 11000 Belgrade, Serbia.
  • University Medical Centre "Bežanijska kosa", University of Belgrade, 11000 Belgrade, Serbia.
  • Faculty of Biology, University of Belgrade, 11000 Belgrade, Serbia.
  • Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.
  • Medical Oncology Department, Oncology Institute of Vojvodina, 21000 Novi Sad, Serbia.

ORCID-Profile: Zoran Todorović, Siniša Đurašević, Lazar Popović

Förderung

  • Ministry of Education, science and Technological Development of Serbia

Zitieren

APA

Pejčić, T., Todorović, Z., Đurašević, S., & Popović, L. (2023). Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032939

Vancouver

Pejčić T, Todorović Z, Đurašević S, Popović L. Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032939

BibTeX
@article{Peji2023,
  author = {Pejčić, Tomislav and Todorović, Zoran and Đurašević, Siniša and Popović, Lazar},
  title = {Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032939}
}
Kostenlos starten →